On June 7, 2021, the United States Drug Administration (FDA) approved a new drug for Alzheimer's disease.

Get to know the opinion of Professor Joaquim Ferreira, in an interview given to the European Association of Parkinson's Diseases (EPDA), where he talks about the Coronavirus and treatment for Parkinson’s disease.

Get to know the opinion of Professor Joaquim Ferreira, in an interview given to the European Association of Parkinson's Diseases (EPDA), where he talks about the importance of the various areas in the treatment of Parkinson's disease and the online resources that we launched in these months.

In order to share and facilitate to schedule a CNS Program we have created a set of tutorials to help you.

Even far apart, we want to be present to support neurological patients and their families.

Even far apart, we want to be present to support neurological patients and their families.

Together, we turn crisis into an opportunity!

New challenges ask for new solutions.